MMP2-Targeting and Redox-Responsive PEGylated Chlorin e6 Nanoparticles for Cancer Near-Infrared Imaging and Photodynamic Therapy

Authors:

Abstract
A unique matrix metalloproteinase-2 (MMP2)-targeted photosensitizer delivery platform was developed in this study for tumor-targeting imaging and photodynamic therapy (PDT). Chlorin e6 (Ce6) as a model photosensitizer therapeutic agent was first covalent conjugated with MMP2-cleavable polypeptide and then modified with mPEG-COOH via a redox-responsive cleavable disulfide linker. The resultant MMP2-cleavable polypeptide modified PEGylated Ce6 nanoparticles (PEG-SS-Ce6-MMP2 NPs), which formed via self-assembly, were observed to be monodisperse and significantly stable in aqueous solution. In addition, owing to their cellular redox-responsiveness at the cleavable disulfide linker, the PEG-SS-Ce6-MMP2 NPs were able to release Ce6 rapidly. Despite displaying enhanced intracellular internalization, the formed PEG-SS-Ce6-MMP2 NPs did not compromise their phototoxic effects towards A549 cancer cells when compared with free Ce6 and PEGylated Ce6 nanoparticles (PEG-SS-Ce6 NPs). In vivo experiments further revealed ...
Funding Information
  • Ministry of Science and Technology of the People's Republic of China (2012AA022703, 2014AA020701, 2015CB931802)
  • Science and Technology Commission of Shanghai Municipality (13NM1401500)
  • National Natural Science Foundation of China (31170961, 81028009, 81225010)

This publication has 47 references indexed in Scilit: